Pro Share Advisors LLC Meridian Bioscience Inc Transaction History

Pro Share Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$31.15 - $33.39 $212,069 - $227,319	6,808 New	6,808 $226,000
Q2 2022 Aug 01, 2022	SELL	$23.75 - $31.69 $225,933 - $301,466	-9,513 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$19.97 - $26.94 $23,225 - $31,331	-1,163 Reduced 10.89%	9,513 $246,000
Q4 2021 Feb 08, 2022	BUY	$17.46 - $21.61 $186,402 - $230,708	10,676 New	10,676 $217,000
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $212,346 - $275,377	-12,239 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.01 - $28.32 $7,041 - $11,073	-391 Reduced 3.1%	12,239 $271,000
Q1 2021 May 14, 2021	BUY	$19.76 - $29.89 $47,937 - $72,513	2,426 Added 23.77%	12,630 $332,000
Q4 2020 Feb 09, 2021	BUY	$15.73 - $21.66 $160,508 - $221,018	10,204 New	10,204 $191,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.